Vertebral Technologies, Inc. Crosses 3,000 Implant Milestone for Market-Leading InterFuse® Interbody Devices

Share Article

Vertebral Technologies, Inc. (VTI), an industry leader in innovative spinal fusion implants, announced today that more than 3,000 InterFuse® interbody fusion devices have been implanted.

InterFuse T™ assembly shown

InterFuse T™

By providing a large implant through a less-invasive approach, we give surgeons and patients the best lumbar fusion option available.

Vertebral Technologies, Inc. (VTI), an industry leader in innovative spinal fusion implants, announced today that more than 3,000 InterFuse® interbody fusion devices have been implanted, including the InterFuse S™ and the InterFuse T™. Both devices use the company’s revolutionary interlocking modular technology to implant a large ALIF-sized implant through a small, single posterior or transforaminal incision.

Chairman and CEO, Jeffrey Felt, MD stated: "The continued sales growth and increasing number of surgeon users proves the superiority of our technology. By providing a large implant through a less-invasive approach, we give surgeons and patients the best lumbar fusion option available. We continue our innovative approach to improving spinal therapies through less-invasive approaches and will be bringing two more fusion devices to market in coming months. Additionally, we are very excited about the potential of our InterCushion®, a new motion preserving device that is currently in clinical trial in Canada."

About the InterFuse© Interbody System:

The InterFuse© Interbody System are a pair of modular devices consisting of an integral rail-and-slot multi-segmental system. This system allows the surgeon to customize the width of the device through a less invasive (even minimally invasive) unilateral approach, and it allows for full endplate coverage, similar to an ALIF-approach. The InterFuse T™ and InterFuse S™ are soon to be joined by two more devices to complete the family: the InterFuse T-Duo™ is a second TLIF device and the InterFuse L™ will allow a lateral approach with the benefits of full endplate coverage achieved with a modular device delivered through an MIS tube or a mini-open approach.    

About Vertebral Technologies, Inc:

Vertebral Technologies, Inc. is a privately held company dedicated to the design, development, manufacturing and marketing of medical devices to address painful conditions of the spine through less-invasive surgical approaches.

Vertebral Technologies, Inc. anticipates continued growth through the remainder of 2013.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Eric Fleming
Vertebral Technologies Inc
(952) 912-5400
Email >
Visit website